To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to ...

A cancer drug candidate that, rightly or wrongly, became a flashpoint at FDA, fails on a second try at approval.

The panel had become a flashpoint as RFK Jr.'s health department worked to limit the number of recommended childhood shots.

The Justice Department's actions on illegal vapes pales next to the scale of the problem, anti-smoking advocates say.

In my most honest of moments, what I want from the medical community is the chance to trust it again,” a MAHA advocate writes ...

At a national public health meeting in March, I attended a session that brought together public health professionals, ...

The Trump administration this week acknowledged it made a significant error in figures it used to help justify a fraud ...

CAR-T therapy is toting up more remissions in autoimmune disease, and generating a flood of experimentation and investment.

Zac Jiwa, a federal Medicare official, delivered a eulogy of sorts at a Thursday Medicare event highlighting the successes of ...

In this week's STATus Report, host Alex Hogan dives into how sports betting apps hook users — and how he himself fell for ...

CAR-T therapies are continuing to gain traction in autoimmune disease, with a notable new case. Also, the FDA has withdrawn ...

For decades, venture capitalists have relied on a tried-and-true recipe to make money in biotech. Now that approach is being ...